Published in Cancer Epidemiol Biomarkers Prev on January 20, 2012
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet (2015) 1.20
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PLoS One (2015) 0.89
Telomere length and common disease: study design and analytical challenges. Hum Genet (2015) 0.87
Telomeres and human reproduction. Fertil Steril (2013) 0.86
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Oncotarget (2015) 0.84
Telomere length and mortality following a diagnosis of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.82
The association between telomere length and cancer risk in population studies. Sci Rep (2016) 0.80
The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population. Oncotarget (2016) 0.79
Genetic variation in telomere maintenance genes in relation to ovarian cancer survival. Int J Mol Epidemiol Genet (2012) 0.76
Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome. J Cell Mol Med (2016) 0.75
Telomere measurement by quantitative PCR. Nucleic Acids Res (2002) 18.69
Obesity, cigarette smoking, and telomere length in women. Lancet (2005) 8.59
Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet (2010) 7.62
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet (1994) 7.04
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet (2007) 6.26
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Telomere diseases. N Engl J Med (2009) 5.68
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol (2007) 4.50
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70
Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev (2007) 3.63
Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet (2006) 3.25
Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60
Telomere length in different tissues of elderly patients. Mech Ageing Dev (2000) 2.45
Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol (2006) 2.16
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma. J Pathol (2010) 2.04
Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev (2009) 1.91
Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint. Hum Mutat (2005) 1.73
Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol (2009) 1.54
Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr (2010) 1.50
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol (2010) 1.44
Synchrony in telomere length of the human fetus. Hum Genet (1998) 1.37
Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer (2008) 1.36
Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer (2007) 1.35
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci U S A (1998) 1.11
Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol (2003) 1.11
Terminal restriction fragments of telomere are detectable in plasma and their length correlates with clinical status of ovarian cancer patients. J Int Med Res (2002) 0.95
MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol (2010) 0.90
Telomerase in the ovary. Reproduction (2010) 0.88
Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol (1998) 0.86
Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol (2007) 0.85
The role of telomeres and telomerase in cancer research. Cancer Res (2010) 0.82
Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer. J Int Med Res (1998) 0.78
Effect of viewing smoking in movies on adolescent smoking initiation: a cohort study. Lancet (2003) 9.03
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA (2006) 6.48
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA (2002) 4.32
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol (2006) 3.96
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A (2005) 3.86
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry (2006) 3.70
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev (2007) 3.63
Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol (2005) 3.44
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Occupational sitting and health risks: a systematic review. Am J Prev Med (2010) 2.98
A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol (2008) 2.75
From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol (2006) 2.67
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry (2007) 2.50
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.43
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr (2010) 2.23
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res (2006) 2.20
Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum (2009) 2.19
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med (2011) 2.16
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Comparing Cervical Cytology and Histology Among Human Papillomavirus-Vaccinated and -Unvaccinated Women in an Academic Colposcopy Clinic. Obstet Gynecol (2015) 2.09
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet (2006) 2.02
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med (2008) 2.01
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res (2013) 1.99
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95
The epidemiology of endometriosis. Obstet Gynecol Clin North Am (2003) 1.94
Types and epidemiology of tendinopathy. Clin Sports Med (2003) 1.92
Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.91
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst (2012) 1.82
Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol Oncol (2008) 1.79
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76
Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev (2009) 1.75
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer (2006) 1.71
Effects of lifetime exercise on the outcome of in vitro fertilization. Obstet Gynecol (2006) 1.71
Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet Gynecol (2011) 1.68
A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res (2006) 1.68
Are workplace interventions to reduce sitting effective? A systematic review. Prev Med (2010) 1.64
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res (2011) 1.64
Physical activity and semen quality among men attending an infertility clinic. Fertil Steril (2010) 1.62
Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol (2009) 1.62
Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer (2010) 1.61
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Early exposure to movie smoking predicts established smoking by older teens and young adults. Pediatrics (2009) 1.61
Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomes. Environ Health Perspect (2011) 1.60
Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. Lab Chip (2011) 1.59
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology (2008) 1.56
Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56
Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.56
Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56
The influence of depression and anxiety on risk of adult onset vulvodynia. J Womens Health (Larchmt) (2011) 1.54
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res (2003) 1.53
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer (2010) 1.52
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer (2009) 1.51
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer (2007) 1.47